Cite
HARVARD Citation
Montoro, J. et al. (2021). Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. European journal of haematology. pp. 114-125. [Online].